secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2021-10-27T23:59:59+00:00
Accession:  0001558370-21-013611
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q3 revenue up 81% YoY to $522M; updates FY2021 revenue outlook to $2.015-$2.025B
--------------------------------------------------------------------------------

- Net loss of $84.3M ($0.53 per share) vs $35.9M loss ($0.43) in Q3 2020.
- Adjusted EBITDA rose to $67.4M from $39.5M; total visits 3.9M (+37% YoY).
- U.S. paid membership grew to 52.5M (+2% YoY); chronic care enrollment 0.725M.
- New agreements with CVS Health and Centene for Primary360 primary care model.
- 2021 full-year revenue outlook raised to $2.015B-$2.025B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000155837021013611/0001558370-21-013611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000155837021013611/tdoc-20211027x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-013611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer